Areteia Therapeutics Stock

areteiatx.comHealthcareFounded: 2022Funding to Date: $175MM

Areteia Therapeutics is a clinical stage biotechnology company focused on oral asthma drug development.

Register for Details

For more details on financing and valuation for Areteia Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Areteia Therapeutics.

Register Today

Other companies like Areteia Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM